Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Neurobiol Aging. 2008 Aug 30;31(6):1055–1058. doi: 10.1016/j.neurobiolaging.2008.07.013

Heat shock treatment reduces beta amyloid toxicity in vivo by diminishing oligomers

Yanjue Wu 1,4,*, Zhiming Cao 1,*, William L Klein 3, Yuan Luo 1,2,
PMCID: PMC2921903  NIHMSID: NIHMS200906  PMID: 18762355

Abstract

Heat shock response, mediated by heat shock proteins, is a highly conserved physiological process in multicellular organisms for reestablishment of cellular homeostasis. Expression of heat shock factors and subsequent heat shock protein plays a role in protection against proteotoxicity in invertebrate and vertebrate models. Proteotoxicity due to β-amyloid peptide (Aβ) oligomerization has been linked to the pathogenesis of Alzheimer's disease. Previously, we demonstrated that progressive paralysis induced by expression of human Aβ1-42 in transgenic C. elegans was alleviated by Aβ oligomer inhibitors ginkgo biloba extract and its constituents (Wu, et al., J. Neurosci 2006, 26:13102-13). In this study, we apply a protective heat shock to the transgenic C. elegans and demonstrate: 1) a remarkable delay in paralysis, 2) increased expression of small heat shock protein HSP16.2, and 3) significant reduction of Aβ oligomers in a heat shock time-dependent manner. These results suggest that transient heat shock lessens Aβ toxicity by diminishing Aβ oligomerization, which provide a link between up regulation of endogenous chaperone proteins and protection against Aβ proteotoxicity in vivo.

Keywords: heat shock, Aβ oligomers, Alzheimer's disease, C. elegans

Introduction

The “amyloid cascade hypothesis” predicts that the progression of pathogenesis of Alzheimer's disease (AD) involves multiple factors such as amyloid aggregation, oxidative stress, loss of ion homeostasis, inflammation and subsequent neuronal death (Hardy et al., 2002). The intermediate Aβ oligomers have been shown to be the toxic species in the early stage of AD (Klein et al., 2001; Walsh et al., 2002). In a transgenic C. elegans model of AD, intracellular expression of human Aβ is associated with elevated oxidative stress (Boyd-Kimball et al., 2006), accumulation of Aβ aggregation and progressive paralysis behavior (Link 2005). Small heat shock protein HSP16.2 has been reported to co-localize with Aβ in the transgenic C. elegans (Fonte et al., 2002), and its over expression suppressed the paralysis (Fonte et al., 2007). However, the functional link between HSP and Aβ on protection against Aβ toxicity remains unknown. Heat shock response in C. elegans is a neuronal controlled behavior (Prahlad et al., 2008). Transcription factor HSF-1, which regulates heat shock response by up regulation of heat shock proteins in C. elegans, has been coupled to normal aging and age-related diseases (Hsu et al., 2003). Recently, it also has been associated with dietary restriction (Steinkraus et al., 2008) and insulin-like signaling (Cohen et al., 2006) in protection against proteotoxicity. Previously we reported that Aβ-induced paralysis was reduced by feeding the Aβ worms with agents that inhibit Aβ oligomers, but not with known antioxidants (Wu et al., 2006). In this study, we apply a protective heat shock treatment (2h, 35°C) to Aβ C. elegans and reveal a significant decrease of Aβ toxicity and Aβ oligomers in the transgenic worms. This data is consistent with the view that co-expression of HSP16.2 or other factors induced by heat shock in Aβ C. elegans lessened Aβ toxicity in these worms (Fonte et al. 2007). In addition, it provides new insight into the role of non-invasive physical treatment and endogenous chaperone proteins in regulation of Aβ aggregation and toxicity.

Materials and Methods

C. elegans strains

The transgenic strain CL4176 (Link et al., 2005) expresses intracellular muscle- specific human Aβ1-42. Synchronized eggs were cultured on fresh NGM plates at 16°C in a temperature-controlled incubator (Sheldon, Cornelius, OR).

Paralysis assays

Aβ transgene expression was induced at the 36th h after hatching by up-shifting the temperature from 16°C to 23 °C. The number of paralyzed worms (100 in each treatment group) was scored at one-hour interval until the last one paralyzed (Wu et al. 2006).

Heat shock was given to CL4176 strain at 24th hour after temperature up-shift, by elevating temperature from 23 °C to 35 °C for 2h, followed by returning to 23°C.

H2O2 assay in C. elegans was preformed as previously described (Smith et al., 2003). Age-synchronized Aβ worms (CL4176) were collected at 36 h after temperature up-shift in groups of 40 worms. The worms were subjected to sonication and were collected into 96-well plates.

DCF-DA (50 μM) was added to each well for quantification of fluorescence in a Microplate Fluorescence Reader (Bio-Tek, Winooski, VT) at the excitation at 485 nm and emission at 530 nm. Western blotting of HSP16.2 and Aβ species Following heat shock treatments, the worms were homogenized in the cell lysis buffer (25mM Tris 7.5, 5 mM NaCl, 1mM DTT, 5mMEDTA) with protease inhibitor cocktail (Sigma, Saint Louis, MO). Equal amounts of the total protein (40 μg) were loaded in each lane. Antibody to HSP16.2 was a gift from Dr. C. Link (Fonte et al. 2007). Antibody to Aβ1–17 (6E10, at 1:1000 dilutions) was from Signet (Dedham, MA). Antibody specific to Aβ oligomers (NU4, 1:1000) was generated in W. Klein's lab (Lambert et al., 2007). Anti-mouse IgG or anti-rabbit IgG, (1:5000, Signet) were the secondary antibodies. Mean densities of the Aβ oligomers were analyzed by a gel documentation system (Alpha innotech, Imgen Technologies, CA). Statistical analyses Differences between untreated and heat shock treated groups were analyzed for statistical significance by Independent Student's t Test of two groups using Microsoft Origin 6.0 software (Northampton, MA). P-value < 0.05 is considered statistically significant.

Results

Protective heat shock remarkably delays paralysis in the transgenic C. elegans

We first examined the effect of protective heat shock on Aβ-induced toxicity in a transgenic C. elegans model of AD (strain CL4176). The Aβ worms were heat shocked for 2h at 35°C followed by the paralysis assay. Time course of paralysis revealed that heat shock treatment (HS, filled squares) significantly deferred paralysis compared with non-heat shocked worms (no HS, open circles, Fig 1A). The delayed paralysis was not additive by co-treatment with HS and EGb 761 (100 μg/ml), a ginkgo biloba leave extract that reduced paralysis by inhibiting Aβ oligomers (Wu et al., 2006), compared with either treatment alone (data not shown), suggesting a share mechanism of action. To elucidate the biochemical consequence of heat shock, the levels of H2O2 were measured by DCF assay. As previously reported, the levels of H2O2 were elevated in Aβ worms (Smith et al. 2003), and the effect of heat shock treatment (+HS) significantly opposed the level of H2O2 in both C. elegans strains (Aβ worms) and the non-transgenic control worms (Ctrl worms) compared with no heat shocked controls (-HS, Fig.1B, *p<0.05; **p<0.01; n=3). We then determined whether heat shock could induce HSP16.2 over expression using Western blotting in the worms after increasing time of heat shock treatment. A notable enhancement of HSP16.2 expression was observed in the Aβ worms following 2 h heat shock (Fig.2A, arrow on the right).

Figure 1.

Figure 1

Aβ-induced paralysis (A) and levels of intracellular H2O2 (B) in transgenic C. elegans strain (Aβ worms) or wild type (Ctrl strain) with (+HS) or without (-HS) heat shock for 2h at 35°C. Each group contains 100 worms. Results were from three independent tests. *P<0.05, **P<0.01.

Figure 2.

Figure 2

Western blots of small heat shock protein HSP16.2 (A), Aβ oligomers (antibody NU4) (B) or total Aβ (antibody 6E10) (C) in Aβ worms treated with increasing time of heat shock (0-5h). D. Mean density of Aβ oligomers (NU4) in wild type (Ctrl worms) or Aβ worms, untreated (-HS) or heat shocked (HS) for 2h. Data were obtained from three independent experiments (**P<0.01).

Protective heat shock significantly reduces Aβ oligomers in transgenic C. elegans

Aβ species were detected using either an antibody specific to Aβ oligomers (NU4) or to total Aβ (6E10). Heat shock treatment in Aβ worms considerably reduced several Aβ oligomeric species such as 20 kD and 100 kD as shown with arrows (Fig.2B, Aβ species NU4), but not total Aβ (Fig.2C, Aβ species 6E10), in a time dependent manner. This suggests that heat shock specifically inhibits toxic Aβ oligomers rather than Aβ transgene expression in the worms. Quantitative analysis of Aβ oligomers (NU4) illustrate (Fig. 2D) that heat shock for 2h (HS) significantly decreased the levels of Aβ oilgomers (100 kD) in comparison with the untreated controls (-HS 100% vs. HS 57.7 ± 11.4%, P=0.003, n=3). Although wild type worms (Ctrl worms) also exhibited background NU4 immunoreactivity, heat shock treatment did not affect this level (Fig.2D), signifying specificity to the Aβ oligomers by the heat shock.

Discussion

We have revealed that heat shock remarkably reduced Aβ toxicity in Aβ worms (Fig.1A&2A). The result is consistent with a recent report demonstrating that co-expression of HSP16.2 or other factors induced by heat shock in Aβ worms reduced their paralysis (Fonte et al. 2007). The most important finding in this study is that protective heat shock is associated with reduction of Aβ oligomeric protein, but not Aβ transgene expression (Fig.2B&C). Although the mechanism of the interaction between HSP and Aβ on Aβ toxicity remains unclear, the HSP family in C. elegans has been shown to have chaperone activity in vitro (Hinault et al., 2006) and is homologous to mammalian αB crystalline (Link et al. 2005). The mechanism may also share some common features as EGb 761 which binds to Aβ in vitro and alleviates Aβ toxicity in vivo (Wu et al. 2006). It is possible that activation of multiple members of the HSP family by heat shock treatment is necessary for degradation of Aβ oligomers because heat-shock treatment is known to induce HSF-1 and several heat shock proteins including hsp 70 and hsp16.2 (Prahlad et al., 2008). This may explain undetectable changes of Aβ oligomers by genetic co-expression of HSP16.2 alone in the transgenic C. elegans (Fonte et al. 2007). Interestingly, reduction of polyQ-mediated Huntingtin toxicity was reduced in the worms which required HSF-1 (Steinkraus et al. 2008), and in mammalian cells by 17-DMAG that induces HSP (Herbst et al., 2007). Protection by heat shock proteins may hold true for mammals; that is, up regulation of a stress response is therapeutically beneficial to health and disease. It has been shown that extended exposure to extreme stress is damaging while transient exposure to elevated temperature can generate a cross-protective effect against constant lethal and/or pathological stimulation (Morimoto et al., 1998; Mattson 2004). Taken together, these data implicate that up-regulation of an endogenous defense system by thermal or physical activities would be a potentially useful therapy for Alzheimer's disease.

Acknowledgments

We thank Dr. Chris Link for providing C. elegans strains, HSP16.2 antibody and advice, and Dr. Hiroshi Maruta and Marishka Brown for helpful discussion and editing. This study is supported by NIH grants RO1AT001928 (YL) from NCCAM, and RO1AG022547 (WLK) from NIA.

Footnotes

Disclosure Statement Wu, Y., Cao, Z., Klein, WL and Luo, Y. do not have any actual or potential conflicts of interest with other people or organizations.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Refernces

  1. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce WM, Jr, Klein JB, Ferguson J, Link CD, Butterfield DA. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiol Aging. 2006;27(9):1239–49. doi: 10.1016/j.neurobiolaging.2005.07.001. [DOI] [PubMed] [Google Scholar]
  2. Bieschke J, Perciavalle RM, Kelly JW, Dillin A. Opposing activities protect against age-onset proteotoxicity. Science. 2006;313(5793):1604–10. doi: 10.1126/science.1124646. [DOI] [PubMed] [Google Scholar]
  3. Fonte V, Kapulkin V, Taft A, Fluet A, Friedman D, Link CD. Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA. 2002;99:9439–44. doi: 10.1073/pnas.152313999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fonte V, Kipp DR, Yerg J, 3rd, Merin D, Forrestal M, Wagner E, Roberts CM, Link CD. Suppression of in vivo beta amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J Biol Chem. 2007 doi: 10.1074/jbc.M703339200. [DOI] [PubMed] [Google Scholar]
  5. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6. doi: 10.1126/science.1072994. [DOI] [PubMed] [Google Scholar]
  6. Herbst M, Wanker EE. Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy. Neurodegener Dis. 2007;4:254–60. doi: 10.1159/000101849. [DOI] [PubMed] [Google Scholar]
  7. Hinault MP, Ben-Zvi A, Goloubinoff P. Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J Mol Neurosci. 2006;30:249. doi: 10.1385/JMN:30:3:249. [DOI] [PubMed] [Google Scholar]
  8. Hsu AL, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science. 2003;300(5622):1142–5. doi: 10.1126/science.1083701. [DOI] [PubMed] [Google Scholar]
  9. Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 2001;24(4):219–24. doi: 10.1016/s0166-2236(00)01749-5. [DOI] [PubMed] [Google Scholar]
  10. Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL. Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem. 2007;100(1):23–35. doi: 10.1111/j.1471-4159.2006.04157.x. [DOI] [PubMed] [Google Scholar]
  11. Link CD. Invertebrate models of Alzheimer's disease. Genes Brain Behav. 2005;4(3):147–56. doi: 10.1111/j.1601-183X.2004.00105.x. [DOI] [PubMed] [Google Scholar]
  12. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430:631–9. doi: 10.1038/nature02621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol. 1998;16(9):833–8. doi: 10.1038/nbt0998-833. [DOI] [PubMed] [Google Scholar]
  14. Prahlad V, Cornelius T, Morimoto RI. Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science. 2008;320(5877):811–4. doi: 10.1126/science.1156093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis. 2003;5(4):287–300. doi: 10.3233/jad-2003-5404. [DOI] [PubMed] [Google Scholar]
  16. Steinkraus KA, Smith ED, Davis C, Carr D, Pendergrass WR, Sutphin GL, Kennedy BK, Kaeberlein M. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell. 2008 doi: 10.1111/j.1474-9726.2008.00385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535–9. doi: 10.1038/416535a. [DOI] [PubMed] [Google Scholar]
  18. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci. 2006;26(50):13102–13. doi: 10.1523/JNEUROSCI.3448-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES